<DOC>
	<DOCNO>NCT02105168</DOCNO>
	<brief_summary>Lung Cancer melanoma relapse frequently whereas sensitive treatment chemotherapy radiotherapy . The purpose study well understanding patient relapse use next generation sequence identify rare mutation assess predictive value .</brief_summary>
	<brief_title>Identification Marker Primary Acquired Resistance Anti Tumorous Treatment</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>1 . Cytological histological diagnosis SCLC , NSCLC melanoma 2 . Patients age &gt; /= 18 year old 3 . Indication treatment use platinum salt lung cancer except patient NSCLC treat surgery platinum salt indicate 4 . If biopsy propose , lesion lust easily accessible 5 . Signed informed consent 1 . Patients unable follow protocol 2 . Consent refusal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>